HER2-positive breast cancer is defined as HER2 gene amplification or HER2 protein overexpression, and HER2-positive tumors grow faster and spread more easily than HER2-negative tumors [8], but the good news is that these tumors can respond better to targeted drugs [9]. This evidence concerns the gene ERBB2 and breast cancer.